These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 3438618)

  • 1. Early termination of clinical trials with prolonged observation of individual patients: a case study.
    van Es GA; Tijssen JG; Lubsen J; van Strik R
    Stat Med; 1987 Dec; 6(8):927-37. PubMed ID: 3438618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adaptive Designs with Discrete Test Statistics and Consideration of Overrunning.
    Schmidt R; Burkhardt B; Faldum A
    Methods Inf Med; 2015; 54(5):434-46. PubMed ID: 26429500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring a randomized clinical trial for futility: the north-Norwegian lidocaine intervention trial.
    Berntsen RF; Rasmussen K; Bjørnstad JF
    Stat Med; 1991 Mar; 10(3):405-12. PubMed ID: 2028124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The application of therapeutic-trial principles to improve the design of epidemiologic research: a case-control study suggesting that anticoagulants reduce mortality in patients with myocardial infarction.
    Horwitz RI; Feinstein AR
    J Chronic Dis; 1981; 34(12):575-83. PubMed ID: 7031074
    [No Abstract]   [Full Text] [Related]  

  • 5. Assessment of futility in clinical trials.
    Snapinn S; Chen MG; Jiang Q; Koutsoukos T
    Pharm Stat; 2006; 5(4):273-81. PubMed ID: 17128426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The FDA's critique of the anturane reinfarction trial.
    Temple R; Pledger GW
    N Engl J Med; 1980 Dec; 303(25):1488-92. PubMed ID: 7432418
    [No Abstract]   [Full Text] [Related]  

  • 7. Increasing the sample size when the unblinded interim result is promising.
    Chen YH; DeMets DL; Lan KK
    Stat Med; 2004 Apr; 23(7):1023-38. PubMed ID: 15057876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Coronary Drug Project. Experimental design features.
    Canner PL; Klimt CR
    Control Clin Trials; 1983 Dec; 4(4):313-32. PubMed ID: 6675887
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical trial designs based on sequential conditional probability ratio tests and reverse stochastic curtailing.
    Tan M; Xiong X; Kutner MH
    Biometrics; 1998 Jun; 54(2):682-95. PubMed ID: 9629648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of power and sample size in the design of clinical trials with failure-time endpoints and interim analyses.
    Gu M; Lai TL
    Control Clin Trials; 1999 Oct; 20(5):423-38. PubMed ID: 10503802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticoagulants after myocardial infarction.
    Loeliger EA; Roos J; Tijssen JG; de Vries WA
    Lancet; 1981 Jun; 1(8233):1321. PubMed ID: 6112639
    [No Abstract]   [Full Text] [Related]  

  • 12. A double-blind trial to assess long-term oral anticoagulant therapy in elderly patients after myocardial infarction. Report of the Sixty Plus Reinfarction Study Research Group.
    Lancet; 1980 Nov; 2(8202):989-94. PubMed ID: 6107674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Data monitoring in clinical trials: the case for stochastic curtailment.
    Davis BR; Hardy RJ
    J Clin Epidemiol; 1994 Sep; 47(9):1033-42. PubMed ID: 7730906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of acute and long-term beta-adrenergic blockade with alprenolol in definite or suspected myocardial infarction. Background and aims of the study.
    Jürgensen HJ
    Acta Med Scand Suppl; 1984; 680():4-7. PubMed ID: 6375279
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of the effects of losartan and captopril on mortality in patients after acute myocardial infarction: the OPTIMAAL trial design. Optimal Therapy in Myocardial Infarction with the Angiotensin II Antagonist Losartan.
    Dickstein K; Kjekshus J
    Am J Cardiol; 1999 Feb; 83(4):477-81. PubMed ID: 10073846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An overview of six clinical trials of aspirin in coronary heart disease.
    Canner PL
    Stat Med; 1987; 6(3):255-67. PubMed ID: 3303251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical trial methodology.
    Peto R
    Biomedicine; 1978 Sep; 28 Spec No():24-36. PubMed ID: 363191
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of anticoagulant agents in acute myocardial infarction: statistics of clinical judgment?
    Selzer A
    Am J Cardiol; 1978 Jun; 41(7):1315-7. PubMed ID: 665539
    [No Abstract]   [Full Text] [Related]  

  • 19. TIMI 11B. Enoxaparin versus unfractionated heparin for unstable angina or non-Q-wave myocardial infarction: a double-blind, placebo-controlled, parallel-group, multicenter trial. Rationale, study design, and methods. Thrombolysis in Myocardial Infarction (TIMI) 11B Trial Investigators.
    Antman EM
    Am Heart J; 1998 Jun; 135(6 Pt 3 Su):S353-60. PubMed ID: 9628449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization of adaptive designs: efficiency evaluation.
    Menon S; Chang M
    J Biopharm Stat; 2012; 22(4):641-61. PubMed ID: 22651106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.